PHIBRO ANIMAL HEALTH CORP Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Phibro Animal Health Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2012 to Q3 2024.
  • Phibro Animal Health Corp Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $6.98M.
  • Phibro Animal Health Corp Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was $17.4M, a 16.1% decline year-over-year.
  • Phibro Animal Health Corp annual Net Income (Loss) Attributable to Parent for 2024 was $2.42M, a 92.6% decline from 2023.
  • Phibro Animal Health Corp annual Net Income (Loss) Attributable to Parent for 2023 was $32.6M, a 33.7% decline from 2022.
  • Phibro Animal Health Corp annual Net Income (Loss) Attributable to Parent for 2022 was $49.2M, a 9.58% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $17.4M $6.98M +$15M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $2.42M $752K -$10.7M -93.5% Apr 1, 2024 Jun 30, 2024 10-K 2024-08-28
Q1 2024 $13.2M $8.41M -$1.64M -16.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $14.8M $1.27M -$5.94M -82.3% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-07
Q3 2023 $20.7M -$8.02M -$11.9M -308% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $32.6M $11.5M +$4.01M +53.6% Apr 1, 2023 Jun 30, 2023 10-K 2024-08-28
Q1 2023 $28.6M $10M -$7.65M -43.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $36.2M $7.21M -$10.3M -58.7% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-07
Q3 2022 $46.5M $3.86M -$2.68M -41% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $49.2M $7.49M -$9.63M -56.3% Apr 1, 2022 Jun 30, 2022 10-K 2024-08-28
Q1 2022 $58.8M $17.7M +$5.53M +45.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $53.3M $17.5M +$4.66M +36.4% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-08
Q3 2021 $48.6M $6.53M -$5.77M -46.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $54.4M $17.1M +$11.5M +203% Apr 1, 2021 Jun 30, 2021 10-K 2023-08-30
Q1 2021 $42.9M $12.2M -$1.34M -9.93% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $44.2M $12.8M +$907K +7.63% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-09
Q3 2020 $43.3M $12.3M +$9.79M +389% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $33.6M $5.64M -$3.16M -35.9% Apr 1, 2020 Jun 30, 2020 10-K 2022-08-24
Q1 2020 $36.7M $13.5M -$1.35M -9.08% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $38.1M $11.9M -$2.85M -19.4% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-03
Q3 2019 $40.9M $2.52M -$13.8M -84.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $54.7M $8.8M -$13.3M -60.2% Apr 1, 2019 Jun 30, 2019 10-K 2021-08-25
Q1 2019 $68M $14.8M -$4.99M -25.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $73M $14.7M +$7.72M +110% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-03
Q3 2018 $65.3M $16.3M +$422K +2.66% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-04
Q2 2018 $64.9M $22.1M +$6.74M +43.8% Apr 1, 2018 Jun 30, 2018 10-K 2020-08-26
Q1 2018 $58.1M $19.8M -$3.8M -16.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-06
Q4 2017 $61.9M $7.03M -$6.39M -47.6% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-06
Q3 2017 $68.3M $15.9M +$3.72M +30.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $64.6M $15.4M +$158K +1.04% Apr 1, 2017 Jun 30, 2017 10-K 2019-08-27
Q1 2017 $64.5M $23.6M +$5.07M +27.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-07
Q4 2016 $59.4M $13.4M -$16.8M -55.5% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-05
Q3 2016 $76.2M $12.2M -$6.58M -35.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-06
Q2 2016 $82.7M $15.2M +$4.82M +46.3% Apr 1, 2016 Jun 30, 2016 10-K 2018-08-27
Q1 2016 $77.9M $18.6M +$1.88M +11.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 $76M $30.2M +$15.9M +112% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-06
Q3 2015 $60.1M $18.8M -$179K -0.95% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $60.3M $10.4M +$28M Apr 1, 2015 Jun 30, 2015 10-K 2015-09-10
Q1 2015 $32.2M $16.7M +$10.3M +162% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $21.9M $14.2M +$11.9M +519% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-09
Q3 2014 $9.96M $18.9M +$13.1M +224% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$3.13M -$17.6M -$23.6M -395% Apr 1, 2014 Jun 30, 2014 10-K 2015-09-10
Q1 2014 $20.5M $6.37M +$2.19M +52.4% Jan 1, 2014 Mar 31, 2014 10-K 2015-09-10
Q4 2013 $18.3M $2.3M -$9.77M -80.9% Oct 1, 2013 Dec 31, 2013 10-K 2015-09-10
Q3 2013 $28.1M $5.84M +$3.18M +120% Jul 1, 2013 Sep 30, 2013 10-K 2015-09-10
Q2 2013 $24.9M $5.98M Apr 1, 2013 Jun 30, 2013 10-K 2014-09-18
Q1 2013 $4.18M Jan 1, 2013 Mar 31, 2013 10-K 2014-09-18
Q4 2012 $12.1M Oct 1, 2012 Dec 31, 2012 10-K 2014-09-18
Q3 2012 $2.66M Jul 1, 2012 Sep 30, 2012 10-K 2014-09-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.